Inarigivir Uses, Dosage, Side Effects and more

Inarigivir is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)).

Trade Name Inarigivir
Generic Inarigivir
Type
Formula C20H26N7O10PS
Weight Average: 587.5
Monoisotopic: 587.119948237
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share